Screener · short volume
Short volume screener
Screen US-listed companies by FINRA daily short volume. Filter by market cap, sector, and industry, and sort by short %, short volume, total volume, or market cap.
1D · FINRA Reg SHO · as of Aug 25, 2026
| # | Ticker | Company | Sector | Market cap | Short | Total | Short % |
|---|---|---|---|---|---|---|---|
| 1 | ANRO | Alto Neuroscience Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.42B | 179.9K | 213.8K | 84.2% |
| 2 | PCRX | Pacira BioSciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.02B | 115.9K | 139.3K | 83.2% |
| 3 | RMD | ResMed Inc. | Health CareMedical/Dental Instruments | $34.13B | 540.3K | 650.2K | 83.1% |
| 4 | IART | Integra LifeSciences Holdings Corporation | Health CareMedical/Dental Instruments | $1.31B | 91.4K | 111.4K | 82.0% |
| 5 | CGEM | Cullinan Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $1.48B | 131.2K | 161.8K | 81.1% |
| 6 | NVST | Envista Holdings Corporation | Health CareMedical/Dental Instruments | $4.41B | 808.2K | 997.5K | 81.0% |
| 7 | TFX | Teleflex Incorporated | Health CareMedical/Dental Instruments | $5.94B | 101.0K | 124.7K | 81.0% |
| 8 | HSIC | Henry Schein Inc. | Health CareMedical Specialities | $9.99B | 239.8K | 296.7K | 80.8% |
| 9 | HROW | Harrow Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.55B | 162.4K | 201.5K | 80.6% |
| 10 | JAZZ | Jazz Pharmaceuticals plc | Health CareBiotechnology: Pharmaceutical Preparations | $16.89B | 560.0K | 695.9K | 80.5% |
| 11 | NVCT | Nuvectis Pharma Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $844.4M | 86.7K | 108.3K | 80.1% |
| 12 | KYMR | Kymera Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $10.53B | 319.9K | 400.0K | 80.0% |
| 13 | CORT | Corcept Therapeutics Incorporated | Health CareBiotechnology: Pharmaceutical Preparations | $13.36B | 210.8K | 267.8K | 78.7% |
| 14 | CYTK | Cytokinetics Incorporated | Health CareBiotechnology: Pharmaceutical Preparations | $10.77B | 443.8K | 568.1K | 78.1% |
| 15 | SABS | SAB Biotherapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $346.7M | 123.5K | 160.1K | 77.1% |
| 16 | OGN | Organon & Co. | Health CareBiotechnology: Pharmaceutical Preparations | $3.61B | 1.11M | 1.44M | 76.9% |
| 17 | DARE | Dare Bioscience Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $19.3M | 229.6K | 300.2K | 76.5% |
| 18 | PRKS | United Parks & Resorts Inc. | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $1.98B | 155.6K | 203.7K | 76.4% |
| 19 | EPRX | Eupraxia Pharmaceuticals Inc. | Health CarePharmaceuticals and Biotechnology | $489.0M | 153.2K | 201.1K | 76.2% |
| 20 | BLLN | BillionToOne Inc. | Health CareMedical Specialities | $4.72B | 327.5K | 432.4K | 75.7% |
| 21 | ARQT | Arcutis Biotherapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $3.12B | 306.7K | 405.3K | 75.7% |
| 22 | KALV | KalVista Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.44B | 366.4K | 485.4K | 75.5% |
| 23 | IRTC | iRhythm Holdings Inc. | Health CareMedical/Dental Instruments | $4.06B | 107.5K | 143.0K | 75.2% |
| 24 | SUPN | Supernus Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.64B | 109.0K | 145.2K | 75.0% |
| 25 | DGX | Quest Diagnostics Incorporated | Health CareMedical Specialities | $26.99B | 252.8K | 337.9K | 74.8% |
| 26 | LIVN | LivaNova PLC | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $4.37B | 130.3K | 175.1K | 74.4% |
| 27 | ALGN | Align Technology Inc. | Health CareIndustrial Specialties | $11.34B | 213.8K | 288.8K | 74.0% |
| 28 | LBRX | LB Pharmaceuticals Inc | Health CareBiotechnology: Pharmaceutical Preparations | $1.57B | 78.4K | 106.0K | 74.0% |
| 29 | HCA | HCA Healthcare Inc. | Health CareHospital/Nursing Management | $92.83B | 177.1K | 240.3K | 73.7% |
| 30 | ALC | Alcon Inc. | Health CareOphthalmic Goods | $36.66B | 246.4K | 336.0K | 73.3% |
| 31 | BCAX | Bicara Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.63B | 87.3K | 119.1K | 73.3% |
| 32 | FOLD | Amicus Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $4.55B | 1.18M | 1.61M | 73.2% |
| 33 | RDNT | RadNet Inc. | Health CareMedical Specialities | $6.05B | 117.8K | 161.0K | 73.2% |
| 34 | MIRM | Mirum Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $6.37B | 125.8K | 172.3K | 73.0% |
| 35 | VCEL | Vericel Corporation | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $2.21B | 143.8K | 197.4K | 72.8% |
| 36 | ADVB | Advanced Biomed Inc. | Health CareMedical Specialities | $15.2M | 223.1K | 306.9K | 72.7% |
| 37 | MMSI | Merit Medical Systems Inc. | Health CareMedical/Dental Instruments | $5.44B | 274.3K | 377.5K | 72.7% |
| 38 | CGON | CG Oncology Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $7.00B | 156.1K | 215.2K | 72.5% |
| 39 | XNCR | Xencor Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.18B | 373.8K | 516.9K | 72.3% |
| 40 | INCY | Incyte Corp. | Health CareBiotechnology: Commercial Physical & Biological Resarch | $26.29B | 356.9K | 495.4K | 72.1% |
| 41 | CDRE | Cadre Holdings Inc. | Health CareIndustrial Specialties | $1.34B | 147.4K | 204.9K | 72.0% |
| 42 | DVA | DaVita Inc. | Health CareMisc Health and Biotechnology Services | $11.34B | 136.8K | 191.0K | 71.6% |
| 43 | CYH | Community Health Systems Inc. | Health CareHospital/Nursing Management | $418.8M | 236.9K | 331.5K | 71.5% |
| 44 | VRTX | Vertex Pharmaceuticals Incorporated | Health CareBiotechnology: Pharmaceutical Preparations | $140.13B | 174.3K | 244.9K | 71.2% |
| 45 | IDYA | IDEAYA Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $4.10B | 278.4K | 391.4K | 71.1% |
| 46 | UHS | Universal Health Services Inc. | Health CareHospital/Nursing Management | $10.36B | 83.8K | 119.0K | 70.4% |
| 47 | ZBIO | Zenas BioPharma Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.20B | 188.1K | 267.3K | 70.4% |
| 48 | MMED | MiniMed Group Inc. | Health CareMedical/Dental Instruments | $5.32B | 405.7K | 577.0K | 70.3% |
| 49 | BTAI | BioXcel Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $23.2M | 634.4K | 902.6K | 70.3% |
| 50 | CNTB | Connect Biopharma Holdings Limited | Health CareBiotechnology: Pharmaceutical Preparations | $154.3M | 277.5K | 395.1K | 70.2% |
| 51 | CELC | Celcuity Inc. | Health CareMedical Specialities | $4.51B | 173.3K | 247.1K | 70.1% |
| 52 | BLCO | Bausch + Lomb Corporation | Health CareOphthalmic Goods | $6.16B | 143.5K | 204.8K | 70.0% |
| 53 | RLX | RLX Technology Inc. | Health Care Medicinal Chemicals and Botanical Products | $2.77B | 1.03M | 1.47M | 70.0% |
| 54 | GRAL | GRAIL Inc. | Health CareMedical Specialities | $3.69B | 208.3K | 297.9K | 69.9% |
| 55 | MCK | McKesson Corporation | Health CareOther Pharmaceuticals | $105.52B | 220.8K | 315.9K | 69.9% |
| 56 | MD | Pediatrix Medical Group Inc. | Health CareHospital/Nursing Management | $2.19B | 105.9K | 152.2K | 69.6% |
| 57 | LFMD | LifeMD Inc. | Health CareMedical/Nursing Services | $156.7M | 185.3K | 266.4K | 69.6% |
| 58 | CRBU | Caribou Biosciences Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $188.7M | 414.0K | 602.0K | 68.8% |
| 59 | AMGN | Amgen Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $239.09B | 674.2K | 988.1K | 68.2% |
| 60 | MDLN | Medline Inc. | Health CareMedical/Dental Instruments | $46.86B | 1.62M | 2.39M | 68.0% |
| 61 | SPRY | ARS Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $568.8M | 314.9K | 465.7K | 67.6% |
| 62 | MAZE | Maze Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $1.69B | 95.4K | 141.3K | 67.5% |
| 63 | MASI | Masimo Corporation | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $9.42B | 326.1K | 483.2K | 67.5% |
| 64 | XOMA | XOMA Royalty Corporation | Health CareBiotechnology: Pharmaceutical Preparations | $503.8M | 768.4K | 1.14M | 67.4% |
| 65 | RCUS | Arcus Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $4.02B | 142.2K | 211.1K | 67.4% |
| 66 | ARCT | Arcturus Therapeutics Holdings Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $438.9M | 575.0K | 859.5K | 66.9% |
| 67 | BIOT | Biotech Acquisition Company | Health CareBiotechnology: Pharmaceutical Preparations | $12.7M | 78.8K | 118.0K | 66.8% |
| 68 | EMBC | Embecta Corp. | Health CareMedical/Dental Instruments | $285.0M | 272.7K | 408.9K | 66.7% |
| 69 | IMVT | Immunovant Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $8.99B | 185.8K | 279.1K | 66.6% |
| 70 | RCEL | Avita Medical Inc. | Health CareMedical/Dental Instruments | $324.7M | 150.2K | 226.0K | 66.5% |
| 71 | ACHC | Acadia Healthcare Company Inc. | Health CareMedical Specialities | $2.78B | 259.4K | 395.0K | 65.7% |
| 72 | ABOS | Acumen Pharmaceuticals Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $224.2M | 80.8K | 123.1K | 65.6% |
| 73 | NTRA | Natera Inc. | Health CareMedical Specialities | $48.53B | 293.5K | 447.5K | 65.6% |
| 74 | JBIO | Jade Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.39B | 138.5K | 211.5K | 65.5% |
| 75 | STAA | STAAR Surgical Company | Health CareOphthalmic Goods | $1.16B | 143.7K | 219.9K | 65.4% |
| 76 | XRAY | DENTSPLY SIRONA Inc. | Health CareMedical/Dental Instruments | $2.19B | 824.2K | 1.26M | 65.4% |
| 77 | STE | STERIS plc (Ireland) | Health CareIndustrial Specialties | $23.05B | 184.8K | 283.1K | 65.3% |
| 78 | ICLR | ICON plc | Health CareBiotechnology: Commercial Physical & Biological Resarch | $12.93B | 103.2K | 158.3K | 65.2% |
| 79 | LFST | LifeStance Health Group Inc. | Health CareMedical/Nursing Services | $4.69B | 870.4K | 1.34M | 65.2% |
| 80 | DRTS | Alpha Tau Medical Ltd. | Health CareMedical/Dental Instruments | $1.36B | 133.2K | 205.1K | 65.0% |
| 81 | WST | West Pharmaceutical Services Inc. | Health CareMedical/Dental Instruments | $24.52B | 105.1K | 161.8K | 65.0% |
| 82 | COGT | Cogent Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $6.39B | 270.6K | 418.2K | 64.7% |
| 83 | BHC | Bausch Health Companies Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.52B | 871.3K | 1.35M | 64.6% |
| 84 | VNRX | VolitionRX Limited | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $5.2M | 152.0K | 236.0K | 64.4% |
| 85 | SYK | Stryker Corporation | Health CareMedical/Dental Instruments | $126.81B | 529.7K | 822.5K | 64.4% |
| 86 | AXSM | Axsome Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $10.76B | 198.3K | 308.1K | 64.4% |
| 87 | TVTX | Travere Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $6.32B | 259.1K | 402.6K | 64.4% |
| 88 | ACH | Accendra Health Inc. | Health CareMedical Specialities | $89.2M | 415.0K | 646.3K | 64.2% |
| 89 | ADPT | Adaptive Biotechnologies Corporation | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $4.19B | 318.6K | 496.4K | 64.2% |
| 90 | VMD | Viemed Healthcare Inc. | Health CareMisc Health and Biotechnology Services | $346.6M | 103.8K | 161.9K | 64.1% |
| 91 | TMDX | TransMedics Group Inc. | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $3.25B | 111.1K | 173.4K | 64.1% |
| 92 | NVCR | NovoCure Limited | Health CareMedical/Dental Instruments | $2.05B | 208.3K | 326.2K | 63.8% |
| 93 | CGC | Canopy Growth Corporation | Health Care Medicinal Chemicals and Botanical Products | $2.86B | 844.0K | 1.32M | 63.8% |
| 94 | RGEN | Repligen Corporation | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $10.25B | 222.3K | 348.2K | 63.8% |
| 95 | KTTA | Pasithea Therapeutics Corp. | Health CareBiotechnology: Pharmaceutical Preparations | $18.7M | 111.8K | 175.2K | 63.8% |
| 96 | FATE | Fate Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $305.5M | 866.6K | 1.36M | 63.8% |
| 97 | MRNA | Moderna Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $63.41B | 17.19M | 26.94M | 63.8% |
| 98 | GMED | Globus Medical Inc. | Health CareMedical/Dental Instruments | $11.14B | 278.2K | 436.4K | 63.8% |
| 99 | AKAN | Akanda Corp. | Health Care Medicinal Chemicals and Botanical Products | $2.7M | 354.6K | 556.9K | 63.7% |
| 100 | IRD | Opus Genetics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $341.9M | 290.5K | 456.5K | 63.6% |